+91 780-304-0404

Growth in the Pharmaceutical Industry to Drive the US Pharmaceutical Excipient Market

Published: Nov 2020

The US pharmaceutical excipient market is estimated to grow at a CAGR of 7.9% during the forecast period. An exceptional growth for pharmaceutical innovation has been observed in 2015. The US pharmaceutical research sector has been involved in the development of new medicines, and it continues to drive pharmaceutical innovation for patients in the near future. 

Browse the full report description US Pharmaceutical Excipient Market Size, Share & Trends Analysis Report, By Product (Solubilizer & Surfactants/Emulsifiers, Polyols, Carbohydrates, and Specialty Excipients), By Formulation (Oral Formulation, Topical Formulations, Parenteral Formulations, and Other Formulations), and Forecast 2019-2025 at https://www.omrglobal.com/industry-reports/us-pharmaceutical-excipient-market

Licensed Biological Products, 2019

Product

Trade Name

Manufacturer

Albumin

ALBUMINEX

Bio Products Laboratory, USA

Alpha1-Proteinase Inhibitor (Human)

Prolastin

Talecris Biotherapeutics, Inc.

 

Zemaira

Aventis Behring L.L.C.

Anthrax Vaccine Adsorbed

Biothrax

Emergent BioDefense Operations Lansing, Inc

Antihemophilic Factor (Recombinant)

ReFacto

Genetics Institute, Inc

 

NUWIQ

Octapharma USA, Inc

 

Novoeight

Novo Nordisk

Antihemophilic Factor/von Willebrand Factor Complex (Human)

Alphanate

Grifols Biologicals, Inc

Antithrombin (Recombinant)

ATryn

GTC Biotherapeutics, Inc

The growing pharmaceutical and biopharmaceutical drugs industry in the country significantly creates demand for excipients and hence drives the growth of the market in the country. Moreover, the contribution from major players in the country further drives the US pharmaceutical excipient industry. 

For instance, in July 2019, SPI Pharma Inc. partnered with Noramco, Inc. and announced the availability of a new excipient compatibility study for cannabidiol solid oral dosage forms. The study includes various options for the development of cannabidiol (CBD) solid oral dosage forms. The study aimed at starting the formation of finished drug products in patient-friendly dosage forms. 

Market Coverage

• Market number available for – 2018-2025
• Base year- 2018
• Forecast period- 2019-2025
• Segment Covered- By Product and By Formulation Type
• Regions Covered- US
• Competitive Landscape- Colorcon Inc., Merck KGaA, Colorcon Inc., Innophos Holdings, Inc., Lubrizol Corp., and Archer Daniels Midland Co. 

Key questions addressed by the report

• What is the market growth rate?
• Which segment dominates the market in the base year?
• Which segment will project the fastest growth in the market?
• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

US Pharmaceutical Excipient Market- Segmentation

By Products

• Solubilizers & Surfactants/Emulsifiers
• Polyols
• Carbohydrates
• Specialty Excipients

By Formulations

• Oral Formulations
• Topical Formulations
• Parenteral Formulations
• Other Formulations

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/us-pharmaceutical-excipient-market


Need Assistance
  • Contact Person:
    Mr. Anurag Tiwari
  • Call Us :
    +91 780-304-0404
  • Mail Us :
    info@omrglobal.com
Why buy from us?
  • Covers more than 15 major industries, which are further segmented into 90+ sectors
  • 65% of our clients are loyal customers
  • 120+ countries are covered in analysis
  • currently servicing 1000+ customers globally
  • 100+ paid data sources mined to research
  • Our expert team will assist you with all research need and customization
  • Our expert research analyst will resolve your every query before and after purchasing the report